This is not the most recent version of the article. View current version (3 DEC 2013)

Intervention Protocol

Non-antiepileptic drugs for trigeminal neuralgia

  1. L He,
  2. B Wu,
  3. M Zhou

Editorial Group: Cochrane Neuromuscular Disease Group

Published Online: 20 JAN 2003

DOI: 10.1002/14651858.CD004029


How to Cite

He L, Wu B, Zhou M. Non-antiepileptic drugs for trigeminal neuralgia (Protocol). The Cochrane Database of Systematic Reviews 2003, Issue 1. Art. No.: CD004029. DOI: 10.1002/14651858.CD004029.

Author Information

*Dr Li He, Department of Neurology, First University Hospital, West China University of Medical Sciences, Chengdu 610041, Sichuan, CHINA. hlwsy@hotmail.com.

Publication History

  1. Published Online: 20 JAN 2003

SEARCH

This is not the most recent version of the article. View current version (03 DEC 2013)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

The objective of this review is to examine the efficacy of non-antiepileptic drugs used to treat TN.

The following hypotheses will be tested:
1.Therapy A* is more effective in controlling TN than placebo treatment.
2.Therapy A* is more effective in controlling TN than no treatment.
3. Therapy A* is more effective in controlling TN than carbamazepine
4.Therapy B* is more effective in controlling TN than placebo treatment.
5.Therapy B* is more effective in controlling TN than no treatment.
6.Therapy B* is more effective in controlling TN than Therapy A.
7.Therapy B* is more effective in controlling TN than carbamazepine.

*Therapy A = baclofen, pimozide, racemic ketamine, proparacaine and tocainade or any other single non-antiepileptic therapeutic agent studied in the literature.
*Therapy B =combination of any two drugs of Therapy A.